LETROZOLE DEXCEL

Land: Israel

Språk: engelsk

Kilde: Ministry of Health

Aktiv ingrediens:

LETROZOLE

Tilgjengelig fra:

DEXCEL LTD, ISRAEL

ATC-kode:

L02BG04

Legemiddelform:

FILM COATED TABLETS

Sammensetning:

LETROZOLE 2.5 MG

Administreringsrute:

PER OS

Resept typen:

Required

Produsert av:

HAUPT PHARMA MUNSTER GmbH, GERMANY

Terapeutisk gruppe:

LETROZOLE

Terapeutisk område:

LETROZOLE

Indikasjoner:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Autorisasjon dato:

2016-02-29